MODULATION VON SRPX2-VERMITTELTER ANGIOGENESE

European patent · EP2257299 · Deleted

Register entry

Publication number
EP2257299
Application number
EP09718390
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 3, 2009
Published
Dec 8, 2010
Granted
Jul 25, 2018
Deleted
Mar 31, 2020
Reason
Annual fee unpaid
IPC classes
A61K 31/713 (2006.01)
C07K 14/435 (2006.01)
C12N 15/11 (2006.01)
A61K 39/395 (2006.01)
Priority
US 34786 P 07.03.2008
PCT application
PCT/US2009/035831 03.03.2009
PCT publication
WO2009/111444 11.09.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 21, 2020

    Deleted, fee unpaid

    Published in Swissreg on 21.10.2020

  2. Oct 5, 2018

    Agent entered

    Representative
    VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, Nadelberg 3, 4051 Basel

    Published in Swissreg on 05.10.2018

  3. Jul 25, 2018

    Granted

    Published in Swissreg on 25.07.2018

Parties

Holder

Research Development Foundation

402 North Division Street, Carson City, NV 89703, US

Agent

Vossius & Partner Patentanwälte Rechtsanwälte mbB

VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB

Nadelberg 3, 4051 Basel

Inventor

IMHOF, Beat, A.

CH-1211 Geneva 4

MILJKOVIC-LICINA, Marijana

CH-1211 Geneva 4

HAMMEL, Philippe

CH-1211 Geneva 4

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.